These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8521019

  • 1. A steric approach for the design of antihistamines with low muscarinic receptor antagonism.
    Zhang MQ, Walczynski K, Timmerman H.
    Inflamm Res; 1995 Apr; 44 Suppl 1():S90-1. PubMed ID: 8521019
    [No Abstract] [Full Text] [Related]

  • 2. Towards the optimal antihistamine: studies with ebastine.
    Roberts DJ.
    Inflamm Res; 1998 Apr; 47 Suppl 1():S36-7. PubMed ID: 9561405
    [No Abstract] [Full Text] [Related]

  • 3. Optically active analogues of ebastine: synthesis and effect of chirality on their antihistaminic and antimuscarinic activity.
    Zhang MQ, Walczynski K, Ter Laak AM, Timmerman H.
    Chirality; 1994 Apr; 6(8):631-41. PubMed ID: 7857774
    [Abstract] [Full Text] [Related]

  • 4. Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study.
    Zhang MQ, Timmerman H.
    Inflamm Res; 1997 Mar; 46 Suppl 1():S93-4. PubMed ID: 9098782
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of [beta-(Aroylamino)ethyl]piperazines and -piperidines and [2-[(Arylamino)carbonyl]ethyl]piperazines, -pyrazinopyridoindoles, and -pyrazinoisoquinolines. A new class of potent H1 antagonists.
    Saxena M, Agarwal SK, Patnaik GK, Saxena AK.
    J Med Chem; 1990 Nov; 33(11):2970-6. PubMed ID: 1977909
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel imidazole derivatives with subtype-selective antimuscarinic activity (2).
    Miyachi H, Kiyota H, Segawa M.
    Bioorg Med Chem Lett; 1998 Aug 18; 8(16):2163-8. PubMed ID: 9873506
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preclinical comparison of ebastine and other second generation H1-antihistamines.
    Yakuo I, Yabuuchi M, Ito T.
    Pharmacol Toxicol; 2001 Oct 18; 89(4):171-6. PubMed ID: 11881966
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Muscarinic M2 antagonists: anthranilamide derivatives with exceptional selectivity and in vivo activity.
    Clader JW, Billard W, Binch H, Chen LY, Crosby G, Duffy RA, Ford J, Kozlowski JA, Lachowicz JE, Li S, Liu C, McCombie SW, Vice S, Zhou G, Greenlee WJ.
    Bioorg Med Chem; 2004 Jan 15; 12(2):319-26. PubMed ID: 14723952
    [Abstract] [Full Text] [Related]

  • 14. Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models.
    Llupià J, Gras J, Llenas J.
    Arzneimittelforschung; 2003 Jan 15; 53(2):93-7. PubMed ID: 12642964
    [Abstract] [Full Text] [Related]

  • 15. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.
    Łazewska D, Kieć-Kononowicz K, Pertz HH, Stark H, Schunack W, Elz S.
    Pharmazie; 2001 Dec 15; 56(12):927-32. PubMed ID: 11802653
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antagonistic activity at muscarinic receptor subtypes of some 2-carbonyl derivatives of diphenidol.
    Varoli L, Angeli P, Burnelli S, Marucci G, Recanatini M.
    Bioorg Med Chem; 1999 Sep 15; 7(9):1837-44. PubMed ID: 10530931
    [Abstract] [Full Text] [Related]

  • 17. Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.
    Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW.
    Bioorg Med Chem Lett; 2000 Oct 02; 10(19):2209-12. PubMed ID: 11012031
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.
    Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A.
    Drugs R D; 2005 Oct 02; 6(6):371-84. PubMed ID: 16274260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.